Skip to main content
. 2022 Jun 27;38(Suppl 1):i60–i67. doi: 10.1093/bioinformatics/btac221

Fig. 3.

Fig. 3.

Recurrence-free survival probability for patients grouped according to the respective treatment recommendations of BITES, based on the test data from the GBSG Trial 2. For comparison, we show the KM curves for all hormone treated and untreated (control) patients in blue and orange, respectively (shown without error bars for better visibility)